Home/Filings/4/0001209191-03-022312
4//SEC Filing

JENN PAUL 4

Accession 0001209191-03-022312

CIK 0000920465other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:59 PM ET

Size

9.9 KB

Accession

0001209191-03-022312

Insider Transaction Report

Form 4
Period: 2003-09-18
JENN PAUL
VP of Product Development
Transactions
  • Award

    Stock Options (right to buy)

    2003-09-18$4.71/sh+11,250$52,988319,724 total
    Exercise: $4.71Exp: 2013-09-18Common Stock (11,250 underlying)
  • Other

    Common Stock

    2003-06-30$1.48/sh+318$470318 total
  • Award

    Stock Options (right to buy)

    2003-09-18$4.71/sh+33,750$158,963353,474 total
    Exercise: $4.71Exp: 2013-09-18Common Stock (33,750 underlying)
Footnotes (2)
  • [F1]Acquired pursuant to the Company???s Employee Stock Purchase Plan.
  • [F2]The stock options vest and become exercisable monthly over the next three years.

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother

Related Parties

1
  • filerCIK 0001237528

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:59 PM ET
Size
9.9 KB